  :It was an abstract. Can I again please point you to WP:MEDRS. Only a secondary source, ideally a high-quality review article, would be adequate to support claims that a modality like Macula Risk is of clinical use. Please continue the conversation on Talk:Macular degeneration, so other contributors can participate in the discussion.  |  